Table 3 Clinical outcome and impact on oncological treatment

From: Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort

Outcome n (out of 178) Percentage
Hospital admission 125 70.2%
Clinical worsening 47 26.4%
Admission to ICU 16 9.0%
At data cutoff
Death 31 17.4%
Primary cause of death: COVID-19 20  
Primary cause of death: cancer 11  
Never hospitalized 51 28.7%
Still hospitalized 16 9.0%
Discharged 80 44.9%
Impact of COVID-19 on cancer treatment
No change in strategy
No delay in ongoing treatment 51 28.8%
Delay in ongoing treatment 73 41.2%
Change in strategy
Dose modification 2 1.1%
Change of treatment modality 6 3.4%
Change of systemic therapy 7 4.0%
End of treatment (surveillance) 7 4.0%
End of treatment (palliative care or death) 31 17.5%
NA 1  
  1. Data cutoff was 6 May 2020. The median follow-up was 23 d.